LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 159 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $50,598,000 | +4.6% | 497,965 | +5.0% | 0.01% | -12.5% |
| Q3 2016 | $48,390,000 | -18.7% | 474,130 | -5.0% | 0.01% | -20.0% |
| Q2 2016 | $59,553,000 | +17.4% | 499,312 | +5.4% | 0.01% | +25.0% |
| Q1 2016 | $50,712,000 | -1.2% | 473,544 | +0.0% | 0.01% | 0.0% |
| Q4 2015 | $51,330,000 | +26.3% | 473,441 | -0.3% | 0.01% | +14.3% |
| Q3 2015 | $40,657,000 | -22.1% | 474,691 | -8.2% | 0.01% | -12.5% |
| Q2 2015 | $52,200,000 | +18.5% | 517,342 | -9.4% | 0.01% | +14.3% |
| Q1 2015 | $44,037,000 | +42.5% | 571,094 | -1.6% | 0.01% | +40.0% |
| Q4 2014 | $30,897,000 | +20.2% | 580,662 | +6.2% | 0.01% | +25.0% |
| Q3 2014 | $25,696,000 | -30.4% | 546,847 | -7.8% | 0.00% | -33.3% |
| Q2 2014 | $36,944,000 | -3.9% | 593,089 | +3.8% | 0.01% | -14.3% |
| Q1 2014 | $38,430,000 | +33.3% | 571,286 | +4.2% | 0.01% | +40.0% |
| Q4 2013 | $28,831,000 | +16.4% | 548,110 | -4.2% | 0.01% | 0.0% |
| Q3 2013 | $24,771,000 | -1.4% | 572,344 | -14.8% | 0.01% | 0.0% |
| Q2 2013 | $25,128,000 | – | 671,874 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |